Drug Screening Market Trends Highlight AI Integration in Testing Solutions
The global drug screening market is poised for explosive growth in the coming years, with the market projected to reach a valuation of US$28.5 billion by 2032, up from an estimated US$10.2 billion in 2025. This expansion represents a robust compound annual growth rate (CAGR) of 15.8% during the forecast period from 2025 to 2032. The market's surge is being driven by an increasing emphasis on workplace safety, the rise in substance abuse cases, regulatory mandates, and technological innovations in drug testing methodologies.